Immunotherapy Research Group

The Immunotherapy Research Group is engaged in research and development of immune system-based therapies in the context of cancer treatment. Research work covers a wide range of studies focused on stimulating, modifying or enhancing the immune response to destroy cancer cells. Our goal is also to identify new therapeutic targets and develop innovative technologies that can increase the effectiveness and safety of immunotherapy. Currently, the main object of the Group’s research are γδ T lymphocytes, which, thanks to their innate cytotoxic activity, can be used therapeutically.